D. P. Parkin

Stellenbosch University — South Africa

Medicine · Health Sciences

18h-index1.3kcitations42works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotics Pharmacokinetics and Efficacy(14), Tuberculosis Research and Epidemiology(13), Pharmaceutical studies and practices(8), Pneumonia and Respiratory Infections(7), Pneumocystis jirovecii pneumonia detection and treatment(7)

Publications42 total

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid
European Journal of Clinical Pharmacology·2007· 98 cited
The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid
Clinical Infectious Diseases·2004· 89 cited
A review of the determination of the early bactericidal activity of various antituberculosis agents
Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie·2003Open Access
'n Oorsig van die bepaling van die vroeë bakterisidiese aktiwiteit van verskeie antituberkulosemiddels : research and review article
2003
Early bactericidal activity of antituberculosis agents
Expert Review of Anti-infective Therapy·2003· 57 cited
NAT2 slow acetylator function as a risk indicator for age-related cataract formation
Pharmacogenetics·2003· 15 cited
The association of age and elimination of isoniazid : an example of median regression with heteroscedasticity : application
South African Statistical Journal·2003· 2 citedOpen Access
The association of age and elimination of isoniazid : an example of median regression with heteroscedasticity
2003· 1 cited
The early bactericidal activity of amikacin in pulmonary tuberculosis.
PubMed·2001· 33 cited
Population screening for isoniazid acetylator phenotype
Pharmacoepidemiology and Drug Safety·2001· 36 cited
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy·2000· 39 citedOpen Access
Practical management of therapeutic diphenylhydantoin concentrations in children.
PubMed·1999· 3 cited
Massive Posterior Fossa Tuberculous Abscess Developing in a Young Child Treated for Miliary Tuberculosis
Pediatric Neurosurgery·1998· 16 cited
The Early Bactericidal Activity of Ciprofloxacin in Patients with Pulmonary Tuberculosis
American Journal of Respiratory and Critical Care Medicine·1997· 62 cited
The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary Tuberculosis
American Journal of Respiratory and Critical Care Medicine·1997· 124 cited
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
American Journal of Respiratory and Critical Care Medicine·1997· 191 cited
A critical appraisal of the clinical pharmacokinetics of isoniazid
SUNScholar (Stellenbosch University)·1996· 1 citedOpen Access
Drug Treatment of Tuberculosis Meningitis in Children
CNS Drugs·1996· 2 cited
Fluctuation of the volume of distribution of amikacin and its effect on once-daily dosage and clearance in a seriously ill patient
Intensive Care Medicine·1996· 36 cited
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
PubMed·1996· 55 cited
page 1 of 3Next →

Frequent Co-authors

H. I. Seifart(27), Peter R. Donald(16), B. W. Van de Wal(13), P. R. Donald(9), F A Sirgel(9), F J Botha(7), P. P. Van Jaarsveld(7), J. S. Maritz(7), Amour Venter(6), Paul D. van Helden(5), W. L. G. Gent(5), D.A. Mitchison(5), L. L. Spruyt(5), PETER R. DONALD(4), D A Mitchison(4), H. Simon Schaaf(3), Cedric J. Werely(3), Frederick A. Sirgel(3), Pieter van der Bijl(3), Michel L. Vandenplas(2)